Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Neurology (clinical)
Reference9 articles.
1. Vigen, C. L. et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer’s disease: outcomes from CATIE-AD. Am. J. Psychiatry 168, 831–839 (2011).
2. Cummings, J., Lee, G., Zhong, K., Fonseca, J. & Taghva, K. Alzheimer’s disease drug development pipeline: 2021. Alzheimers Dement. (N.Y.) 7, e12179 (2021).
3. Mintzer, J. et al. Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial. JAMA Neurol https://doi.org/10.1001/jamaneurol.2021.3356 (2021).
4. Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V. & Cummings, J. L. Neuropathologic correlates of apathy in Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 21, 144–147 (2006).
5. Miller, D. S. et al. Diagnostic criteria for apathy in neurocognitive disorders. Alzheimers Dement. (2021).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献